Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP Block with Ropivacaine for Postoperative Pain Control
NCT03149783Phase 2Unknown
- Sponsor
- University of Colorado Denver
- Start
- Feb 2018
- Primary completion
- Aug 2021
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain, sponsored by University of Colorado Denver. Status: unknown.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03149783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03149783.